06 Nov Modelling resistance to oral SERDs and CDK4/6 inhibitors in metastatic ER+ breast cancer in patient-derived models (PDXs)

ID: 03251

Authors: Molina, Cristina (1); Monserrat, Laia (1); Ros, Susana (2); Domenech, Heura (1); Herencia, Andrea (1); Oliveira, Mafalda (3); Bellet, Meritxell (3); Viaplana, Cristina (4); Brasó-Maristany, Fara (5,6); Òdena, Andreu (1); Dientsmann, Rodrigo (4); Chandarlapaty, Sarat (7,8); Prat, Aleix (5,6); V Forment, Josep (9); Crafter, Claire (2); Albertella, Mark (9); O’Connor, Mark (9); Morrow, Chris (2); Carnevalli, Larissa (2); Saura, Cristina (4); Serra, Violeta (1)

Topic: INNOVATIVE THERAPIES